Comparison 6. Broad spectrum penicillins, aminoglycosides and antianaerobes versus other regimens.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Mortality (all causes)	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.10 [0.00, 1.99]
2 Mortality (due to infection)	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.14 [0.01, 3.16]
3 Clinical success	1	43	Odds Ratio (M‐H, Random, 95% CI)	2.06 [0.31, 13.81]
3.1 Overall	1	43	Odds Ratio (M‐H, Random, 95% CI)	2.06 [0.31, 13.81]
4 Microbiological success	1	9	Odds Ratio (M‐H, Random, 95% CI)	0.4 [0.02, 10.02]
5 Wound infection	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.37 [0.03, 4.42]
6 Remote infection	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.57 [0.14, 2.27]
7 Superinfection	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.77 [0.10, 6.06]
8 Adverse reactions	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.78 [0.05, 13.39]
8.1 Minor adverse reactions	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.78 [0.05, 13.39]